“ While millions of people have missed their second shots, the overall rates of follow-through, with some 92 percent getting fully vaccinated, are strong by historical standards. Roughly three-quarters of adults come back for their second dose of the vaccine that protects against shingles.”
Things are going relatively well, headline is overly alarmist.
2. We’re still in the mad rush shots-in-arms phase. There will be a time when the most important thing to do is for people’s doctors to convince skeptics and check that everyone got their booster, but we’re still a ways out from there.
The article is one sided. Is there data that proves that 1 dose of J&J has advantages over 1 dose of Moderna / Pfizer vaccine? Right now these people are giving space for other people to get vaccinated, so what they are doing can save lives (Just like what happened in UK)
Vaccine efficacy (VE) against central laboratory-confirmed moderate to severe/critical COVID19 across all geographic areas in which the trial was conducted was 66.9% (95% CI 59.0, 73.4) when considering cases occurring at least 14 days after the single-dose vaccination and 66.1% (55.0, 74.8) when considering cases occurring at least 28 days after vaccination.
I have seen estimates as low as 40-something % for single doses of the mRNA vaccines, but this may have been an underestimate caused by only considering the first two weeks after inoculation. Given enough time for immunity to fully set in, the real number may be over 90% [2].
HOWEVER, those numbers all refer to symptomatic disease. Prevention of hospitalization and death was 100% in the J&J trial.
[+] [-] entee|4 years ago|reply
“ While millions of people have missed their second shots, the overall rates of follow-through, with some 92 percent getting fully vaccinated, are strong by historical standards. Roughly three-quarters of adults come back for their second dose of the vaccine that protects against shingles.”
Things are going relatively well, headline is overly alarmist.
[+] [-] coffeefirst|4 years ago|reply
1. One shot still cuts the spread, take the win.
2. We’re still in the mad rush shots-in-arms phase. There will be a time when the most important thing to do is for people’s doctors to convince skeptics and check that everyone got their booster, but we’re still a ways out from there.
[+] [-] steverb|4 years ago|reply
Does anyone have a source for that? My quick google search doesn't give me any results that aren't about the Shingrix vaccine.
[+] [-] xiphias2|4 years ago|reply
[+] [-] T-A|4 years ago|reply
Vaccine efficacy (VE) against central laboratory-confirmed moderate to severe/critical COVID19 across all geographic areas in which the trial was conducted was 66.9% (95% CI 59.0, 73.4) when considering cases occurring at least 14 days after the single-dose vaccination and 66.1% (55.0, 74.8) when considering cases occurring at least 28 days after vaccination.
I have seen estimates as low as 40-something % for single doses of the mRNA vaccines, but this may have been an underestimate caused by only considering the first two weeks after inoculation. Given enough time for immunity to fully set in, the real number may be over 90% [2].
HOWEVER, those numbers all refer to symptomatic disease. Prevention of hospitalization and death was 100% in the J&J trial.
[1] https://www.fda.gov/media/146217/download
[2] https://www.nejm.org/doi/full/10.1056/NEJMc2036242
[+] [-] vmception|4 years ago|reply